Loading viewer...
investor_presentation
Format: PDF investor_presentation
QUARTERLY BUSINESS UPDATE May 5, 2022 © 2022 Luminar Technologies, Inc. All Rights Reserved | 1
QUARTERLY BUSINESS UPDATE
© 2022 Luminar Technologies, Inc. All Rights Reserved | 1 DISCLAIMER AND CAUTIONARY NOTE
FORWARD-LOOKING STATEMENTS
This presentation of Luminar Technologies, Inc. (“Luminar” or the “Company”) includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements may be identified by the use of words such as “future,” “growth,” “opportunity,” “well-positioned,” "forecast," "intend," "seek," "target," “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,”
and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the
expected achievement of series production readiness for Iris lidar and core software, the expected timing of the beta release of Sentinel, the expected growth in 2022 of Luminar’s forward-looking order book and major
commercial wins, and expectations for 2022 revenue growth and cash expenditure. Such forward-looking statements with respect to revenues, earnings, performance, strategies, prospects and other aspects of the business of
Luminar are based on current expectations that are subject to risks and uncertainties. These statements are based on various assumptions, whether or not identified in this presentation, and on the current expectations of
Luminar's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as,
a guarantee, an assurance, a prediction or a definitive statement of fact or probability.
A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Luminar’s history of losses, significant
continuing expenses and limited operating history; the cost of Luminar’s strategic initiatives and the potential failure to increase revenue to offset these initiatives; whether Luminar’s lidar products are selected for inclusion in
autonomous driving or ADAS systems by automotive OEMs or their suppliers, and whether Luminar will be de-selected by any customers; the lengthy period of time from a major commercial win to implementation and the risks of
cancellation or postponement of the contract or unsuccessful implementation; potential inaccuracies in Luminar’s forward looking estimates of certain metrics and future cost of goods sold (COGS) and bill of materials (BOM)
and total addressable market; the discontinuation, lack of success of Luminar’s customers in developing and commercializing products using Luminar’s solutions; Luminar’s inability to reduce and control the cost of the inputs on
Preview truncated — download the full document for the complete content.
investor_presentation
27 Pages
investor_presentation
6 Pages
Pfizer